JP Morgan Chase
INSP icon

JP Morgan Chase’s Inspire Medical Systems INSP Stock Holding History

JP Morgan Chase’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,600
Closed -$337K – 7575
2025
Q2 		$337K Buy
+2,600
New +$377K ﹤0.01% 4978
2025
Q1 		– Sell
-3,100
Closed -$575K – 7518
2024
Q4 		$575K Sell
3,100
-2,300
-43% -$446K ﹤0.01% 4969
2024
Q3 		$1.14M Hold
5,400
– – ﹤0.01% 4383
2024
Q2 		$723K Buy
5,400
+200
+4% +$37.8K ﹤0.01% 4475
2024
Q1 		$1.12M Sell
5,200
-29,300
-85% -$5.74M ﹤0.01% 4266
2023
Q4 		$7.02M Buy
+34,500
New +$5.59M ﹤0.01% 2802

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase's INSP Position: Q1 2026 in Review

JP Morgan Chase increased its Inspire Medical Systems (INSP) stake by 18% in Q1 2026, buying an estimated $576K and bringing the position to 53,615 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3878.

JP Morgan Chase first reported a position in INSP in Q2 2018 and has held it in 32 quarters since. The position peaked at $157M in Q3 2024. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • JP Morgan Chase held 53,615 shares of Inspire Medical Systems worth $2.7M as of Q1 2026.
  • JP Morgan Chase bought 8,227 Inspire Medical Systems shares in Q1 2026, an estimated $576K.
  • Inspire Medical Systems made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3878 holding.
  • JP Morgan Chase first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 32 quarters since.
  • JP Morgan Chase's Inspire Medical Systems position peaked at $157M in Q3 2024.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.